Global Oral Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Oral Vaccines market report explains the definition, types, applications, major countries, and major players of the Oral Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • LLC)

    • GlaxoSmithKline plc

    • Swiss Serum and Vaccine Institute Berne

    • Merial Inc

    • PaxVax Corporation

    • Shantha Biotechnics

    • Bull Bio - NCIPD Ltd

    • Aventis (Sanofi SA)

    • Immunitor Inc

    • Merck Sharp & Dohme Corp

    • VALNEVA Canada Inc

    • QU?MICA SUIZA SA

    • Crucell (Janssen Global Services

    • Serum Institute of India Pvt Ltd

    • Pfizer Inc

    • Vaxart Inc

    By Type:

    • Live Attenuated Vaccines

    • Killed/Inactivated Vaccines

    • Recombinant Vaccines

    • Others

    By End-User:

    • Polio

    • Rabies

    • Rotavirus

    • Cholera

    • HIV

    • Respiratory Infections

    • Influenza

    • Tuberculosis

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oral Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oral Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Oral Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oral Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oral Vaccines Market- Recent Developments

    • 6.1 Oral Vaccines Market News and Developments

    • 6.2 Oral Vaccines Market Deals Landscape

    7 Oral Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Oral Vaccines Key Raw Materials

    • 7.2 Oral Vaccines Price Trend of Key Raw Materials

    • 7.3 Oral Vaccines Key Suppliers of Raw Materials

    • 7.4 Oral Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Oral Vaccines Cost Structure Analysis

      • 7.5.1 Oral Vaccines Raw Materials Analysis

      • 7.5.2 Oral Vaccines Labor Cost Analysis

      • 7.5.3 Oral Vaccines Manufacturing Expenses Analysis

    8 Global Oral Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oral Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oral Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oral Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Killed/Inactivated Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Recombinant Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Polio Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Rabies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Rotavirus Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cholera Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global HIV Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Respiratory Infections Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Influenza Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Tuberculosis Consumption and Growth Rate (2017-2022)

      • 9.2.9 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oral Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Oral Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oral Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Oral Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Oral Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oral Vaccines Consumption (2017-2022)

      • 10.3.2 UK Oral Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Oral Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Oral Vaccines Consumption (2017-2022)

      • 10.3.5 France Oral Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Oral Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Oral Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Oral Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Oral Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Oral Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Oral Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Oral Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Oral Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oral Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Oral Vaccines Consumption (2017-2022)

      • 10.4.3 India Oral Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Oral Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Oral Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Oral Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Oral Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Oral Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Oral Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Oral Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Oral Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Oral Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oral Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Oral Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Oral Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Oral Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Oral Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Oral Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oral Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Oral Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oral Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Oral Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Oral Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Oral Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oral Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oral Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oral Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Oral Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Oral Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Oral Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oral Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Oral Vaccines Consumption (2017-2022)

    11 Global Oral Vaccines Competitive Analysis

    • 11.1 LLC)

      • 11.1.1 LLC) Company Details

      • 11.1.2 LLC) Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 LLC) Oral Vaccines Main Business and Markets Served

      • 11.1.4 LLC) Oral Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GlaxoSmithKline plc

      • 11.2.1 GlaxoSmithKline plc Company Details

      • 11.2.2 GlaxoSmithKline plc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GlaxoSmithKline plc Oral Vaccines Main Business and Markets Served

      • 11.2.4 GlaxoSmithKline plc Oral Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Swiss Serum and Vaccine Institute Berne

      • 11.3.1 Swiss Serum and Vaccine Institute Berne Company Details

      • 11.3.2 Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Swiss Serum and Vaccine Institute Berne Oral Vaccines Main Business and Markets Served

      • 11.3.4 Swiss Serum and Vaccine Institute Berne Oral Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merial Inc

      • 11.4.1 Merial Inc Company Details

      • 11.4.2 Merial Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merial Inc Oral Vaccines Main Business and Markets Served

      • 11.4.4 Merial Inc Oral Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 PaxVax Corporation

      • 11.5.1 PaxVax Corporation Company Details

      • 11.5.2 PaxVax Corporation Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 PaxVax Corporation Oral Vaccines Main Business and Markets Served

      • 11.5.4 PaxVax Corporation Oral Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Shantha Biotechnics

      • 11.6.1 Shantha Biotechnics Company Details

      • 11.6.2 Shantha Biotechnics Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Shantha Biotechnics Oral Vaccines Main Business and Markets Served

      • 11.6.4 Shantha Biotechnics Oral Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bull Bio - NCIPD Ltd

      • 11.7.1 Bull Bio - NCIPD Ltd Company Details

      • 11.7.2 Bull Bio - NCIPD Ltd Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bull Bio - NCIPD Ltd Oral Vaccines Main Business and Markets Served

      • 11.7.4 Bull Bio - NCIPD Ltd Oral Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Aventis (Sanofi SA)

      • 11.8.1 Aventis (Sanofi SA) Company Details

      • 11.8.2 Aventis (Sanofi SA) Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Aventis (Sanofi SA) Oral Vaccines Main Business and Markets Served

      • 11.8.4 Aventis (Sanofi SA) Oral Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Immunitor Inc

      • 11.9.1 Immunitor Inc Company Details

      • 11.9.2 Immunitor Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Immunitor Inc Oral Vaccines Main Business and Markets Served

      • 11.9.4 Immunitor Inc Oral Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Merck Sharp & Dohme Corp

      • 11.10.1 Merck Sharp & Dohme Corp Company Details

      • 11.10.2 Merck Sharp & Dohme Corp Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Merck Sharp & Dohme Corp Oral Vaccines Main Business and Markets Served

      • 11.10.4 Merck Sharp & Dohme Corp Oral Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 VALNEVA Canada Inc

      • 11.11.1 VALNEVA Canada Inc Company Details

      • 11.11.2 VALNEVA Canada Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 VALNEVA Canada Inc Oral Vaccines Main Business and Markets Served

      • 11.11.4 VALNEVA Canada Inc Oral Vaccines Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 QU?MICA SUIZA SA

      • 11.12.1 QU?MICA SUIZA SA Company Details

      • 11.12.2 QU?MICA SUIZA SA Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 QU?MICA SUIZA SA Oral Vaccines Main Business and Markets Served

      • 11.12.4 QU?MICA SUIZA SA Oral Vaccines Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Crucell (Janssen Global Services

      • 11.13.1 Crucell (Janssen Global Services Company Details

      • 11.13.2 Crucell (Janssen Global Services Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Crucell (Janssen Global Services Oral Vaccines Main Business and Markets Served

      • 11.13.4 Crucell (Janssen Global Services Oral Vaccines Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Serum Institute of India Pvt Ltd

      • 11.14.1 Serum Institute of India Pvt Ltd Company Details

      • 11.14.2 Serum Institute of India Pvt Ltd Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Serum Institute of India Pvt Ltd Oral Vaccines Main Business and Markets Served

      • 11.14.4 Serum Institute of India Pvt Ltd Oral Vaccines Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Pfizer Inc

      • 11.15.1 Pfizer Inc Company Details

      • 11.15.2 Pfizer Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Pfizer Inc Oral Vaccines Main Business and Markets Served

      • 11.15.4 Pfizer Inc Oral Vaccines Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Vaxart Inc

      • 11.16.1 Vaxart Inc Company Details

      • 11.16.2 Vaxart Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Vaxart Inc Oral Vaccines Main Business and Markets Served

      • 11.16.4 Vaxart Inc Oral Vaccines Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    12 Global Oral Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Oral Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Killed/Inactivated Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oral Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Polio Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Rabies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Rotavirus Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Cholera Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global HIV Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Respiratory Infections Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Influenza Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.8 Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oral Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Oral Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oral Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oral Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oral Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oral Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oral Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oral Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oral Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oral Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oral Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oral Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oral Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oral Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oral Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oral Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oral Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oral Vaccines

    • Figure of Oral Vaccines Picture

    • Table Global Oral Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oral Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Killed/Inactivated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Polio Consumption and Growth Rate (2017-2022)

    • Figure Global Rabies Consumption and Growth Rate (2017-2022)

    • Figure Global Rotavirus Consumption and Growth Rate (2017-2022)

    • Figure Global Cholera Consumption and Growth Rate (2017-2022)

    • Figure Global HIV Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Consumption and Growth Rate (2017-2022)

    • Figure Global Tuberculosis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Vaccines Consumption by Country (2017-2022)

    • Table North America Oral Vaccines Consumption by Country (2017-2022)

    • Figure United States Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Vaccines Consumption by Country (2017-2022)

    • Figure Germany Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Oral Vaccines Consumption by Country (2017-2022)

    • Figure China Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Oral Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Oral Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Oral Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Oral Vaccines Consumption by Country (2017-2022)

    • Figure Australia Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oral Vaccines Consumption and Growth Rate (2017-2022)

    • Table LLC) Company Details

    • Table LLC) Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table LLC) Oral Vaccines Main Business and Markets Served

    • Table LLC) Oral Vaccines Product Portfolio

    • Table GlaxoSmithKline plc Company Details

    • Table GlaxoSmithKline plc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Oral Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline plc Oral Vaccines Product Portfolio

    • Table Swiss Serum and Vaccine Institute Berne Company Details

    • Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Main Business and Markets Served

    • Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Product Portfolio

    • Table Merial Inc Company Details

    • Table Merial Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merial Inc Oral Vaccines Main Business and Markets Served

    • Table Merial Inc Oral Vaccines Product Portfolio

    • Table PaxVax Corporation Company Details

    • Table PaxVax Corporation Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Corporation Oral Vaccines Main Business and Markets Served

    • Table PaxVax Corporation Oral Vaccines Product Portfolio

    • Table Shantha Biotechnics Company Details

    • Table Shantha Biotechnics Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shantha Biotechnics Oral Vaccines Main Business and Markets Served

    • Table Shantha Biotechnics Oral Vaccines Product Portfolio

    • Table Bull Bio - NCIPD Ltd Company Details

    • Table Bull Bio - NCIPD Ltd Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bull Bio - NCIPD Ltd Oral Vaccines Main Business and Markets Served

    • Table Bull Bio - NCIPD Ltd Oral Vaccines Product Portfolio

    • Table Aventis (Sanofi SA) Company Details

    • Table Aventis (Sanofi SA) Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aventis (Sanofi SA) Oral Vaccines Main Business and Markets Served

    • Table Aventis (Sanofi SA) Oral Vaccines Product Portfolio

    • Table Immunitor Inc Company Details

    • Table Immunitor Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunitor Inc Oral Vaccines Main Business and Markets Served

    • Table Immunitor Inc Oral Vaccines Product Portfolio

    • Table Merck Sharp & Dohme Corp Company Details

    • Table Merck Sharp & Dohme Corp Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Corp Oral Vaccines Main Business and Markets Served

    • Table Merck Sharp & Dohme Corp Oral Vaccines Product Portfolio

    • Table VALNEVA Canada Inc Company Details

    • Table VALNEVA Canada Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table VALNEVA Canada Inc Oral Vaccines Main Business and Markets Served

    • Table VALNEVA Canada Inc Oral Vaccines Product Portfolio

    • Table QU?MICA SUIZA SA Company Details

    • Table QU?MICA SUIZA SA Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table QU?MICA SUIZA SA Oral Vaccines Main Business and Markets Served

    • Table QU?MICA SUIZA SA Oral Vaccines Product Portfolio

    • Table Crucell (Janssen Global Services Company Details

    • Table Crucell (Janssen Global Services Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crucell (Janssen Global Services Oral Vaccines Main Business and Markets Served

    • Table Crucell (Janssen Global Services Oral Vaccines Product Portfolio

    • Table Serum Institute of India Pvt Ltd Company Details

    • Table Serum Institute of India Pvt Ltd Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd Oral Vaccines Main Business and Markets Served

    • Table Serum Institute of India Pvt Ltd Oral Vaccines Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Oral Vaccines Main Business and Markets Served

    • Table Pfizer Inc Oral Vaccines Product Portfolio

    • Table Vaxart Inc Company Details

    • Table Vaxart Inc Oral Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vaxart Inc Oral Vaccines Main Business and Markets Served

    • Table Vaxart Inc Oral Vaccines Product Portfolio

    • Figure Global Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Killed/Inactivated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polio Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rabies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rotavirus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholera Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oral Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oral Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.